E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Acadia Pharmaceuticals Inc. > News item
Published on 3/30/2012 in the Prospect News PIPE Daily.

Acadia Pharmaceuticals negotiates $20 million at-the-market offering

Company reports plans for equity sales with MLV in Friday 8-K filing

By Devika Patel

Knoxville, Tenn., March 30 - Acadia Pharmaceuticals Inc. arranged a $20 million at-the-market issuance sales agreement with MLV & Co. LLC on March 30, according to an 8-K filed Friday with the Securities and Exchange Commission.

San Diego-based Acadia is a biopharmaceutical company that develops treatments for central nervous system disorders.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.